When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Botulism

Last reviewed: 2 Jun 2025
Last updated: 15 Apr 2025

Summary

Definition

History and exam

Key diagnostic factors

  • ingestion of contaminated foods
  • infant age group
  • biologic terrorism
  • blurred vision and diplopia
  • impaired accommodation
  • ptosis
  • oculobulbar weakness
  • hypoglossal weakness
  • dysarthria
  • dysphagia
  • symmetrical descending flaccid paralysis
完整详情

其他诊断因素

  • hypotonia
  • weakened cry in infants
  • feeding difficulties in infants
  • postural hypotension
  • hypothermia
  • urinary retention
  • constipation
  • dry mouth and throat
  • gastrointestinal illness
  • diminished or absent deep tendon reflexes
  • absence of fever
  • respiratory dysfunction
  • pupillary dilation
完整详情

危险因素

  • ingestion of contaminated foods
  • ingestion of honey in infants
  • ingestion of soil in infants
  • intravenous drug use
  • crush injury
  • infant age group
  • abnormal bowel anatomy
  • therapeutic or cosmetic use of botulinum toxin
  • biologic terrorism
  • exposure to reptiles
完整详情

诊断性检查

首要检查

  • mouse bioassay of serum, gastric secretions, stool, or food samples
  • culture of food samples, gastric aspirates, or fecal material
完整详情

需考虑的检查

  • electrophysiologic testing
完整详情

新兴检查

  • enzyme-linked immunosorbent assay (ELISA)
  • polymerase chain reaction (PCR)

治疗流程

急症处理

foodborne botulism

wound botulism

iatrogenic botulism

inhalational botulism (biological attack)

撰稿人

作者

Linda S. Nield, MD, FAAP
Linda S. Nield

Professor of Pediatrics and Medical Education

West Virginia University School of Medicine

Morgantown

WV

利益声明

LSN is an author of a reference cited in this topic.

鸣谢

Dr Linda S. Nield would like to gratefully acknowledge Dr Thomas P. Bleck, Dr Aimee Hodowanec, Dr Pavani Reddy, and Dr Teresa Zembower, previous contributors to this topic.

利益声明

TPB, AH, PR, and TZ declare that they have no competing interests.

同行评议者

Fiona Cooke, MA, PhD, MSc, FRCPath, MRCP, DTM&H

Research Fellow and Medical Microbiologist

Wellcome Trust Sanger Institute

Department of Microbiology

Addenbrooke's Hospital

Cambridge

UK

利益声明

FC declares that she has no competing interests.

Christopher D. Huston, MD

Assistant Professor of Medicine

Division of Infectious Diseases

University of Vermont College of Medicine

Burlington

VT

利益声明

CDH declares that he has no competing interests.

William A. Petri, Jr, MD, PhD, FACP

Chief and Professor of Medicine

Division of Infectious Diseases and International Health

University of Virginia Health System

Charlottesville

VA

利益声明

WAP declares that he has no competing interests.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Rao AK, Sobel J, Chatham-Stephens K, et al. Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021. MMWR Recomm Rep. 2021 May 7;70(2):1-30.全文  摘要

Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001 Feb 28;285(8):1059-70. 摘要

Centers for Disease Control and Prevention (CDC). Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep. 2010 Mar 19;59(10):299.全文  摘要

Arnon SS, Schechter R, Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006 Feb 2;354(5):462-71.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

内容使用需遵循免责声明